On August 9, Wang Qiang, member of the Standing Committee of the Wuwei Municipal Party Committee and Secretary of the Liangzhou District Party Committee, Xu Junsheng, member of the Standing Committee of the Liangzhou District Party Committee and Executive Deputy District Magistrate, and Li Jingguan, Director of the Liangzhou District Investment Promotion Bureau, visited Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. for research and investigation. Liu Naiyu, Chairman of Quanji Kang, and his management team warmly welcomed the leaders and accompanied them on a tour of the company's exhibition hall and operations and R&D center. During the visit, Chairman Liu Naiyu provided a systematic overview of the company's development history, product portfolio, technological innovation strategies, and progress in the construction of national industrial bases.

Wang Qiang and his delegation inspected the display cabinet of plant-based capsule samples

At the discussion meeting, Chairman Liu Naiyu focused on reporting the progress of the construction of the Wuwei plant-based capsule production base with an annual capacity of 40 billion capsules and the upcoming launch of the intelligent manufacturing project for traditional Chinese medicine oral dissolving films.

Secretary Wang Qiang and his delegation listened to the progress report on the Quanji Kang Wuwei project and the traditional Chinese medicine oral dissolving film project.

The traditional Chinese medicine oral dissolving film project focuses on addressing the application pain points of traditional Chinese medicine, such as difficulty in swallowing and inconvenience in carrying, by adopting modern advanced pharmaceutical technology to create innovative formulations that are natural, safe, green, and intelligent. This promotes the upgrading of traditional Chinese medicine formulations toward standardization, convenience, and youthfulness, aligning with the national pharmaceutical industry development strategy and the local orientation toward new quality productive forces.

Secretary Wang Qiang highly commended Quanji Kang's professional capabilities and technological strengths in the field of plant-based pharmaceutical excipients. He pointed out that the Quanji Kang project's deep integration with Wuwei's local TCM modernization and agricultural industries holds significant advantages. Wuwei City will continue to optimize the business environment, strengthen policy support, and facilitate the project's implementation to promote the deep integration of TCM and new materials, injecting new momentum into industrial upgrading.

This research visit not only reflects Wuwei City's high regard for emerging pharmaceutical industries but also lays a solid foundation for future government-enterprise collaboration and platform co-construction. Quanji Kang will continue to uphold its mission of “promoting medication safety and safeguarding human health,” accelerating project construction progress, leveraging technological innovation to advance the modernization of traditional Chinese medicine, and contributing to the “Healthy China” strategy.